<DOC>
	<DOCNO>NCT00168051</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetic parameter ReFacto Advate , use chromogenetic substrate assay measure plasma Factor VIII activity plasma .</brief_summary>
	<brief_title>Study Comparing Blood Levels ReFacto Advante Hemophilia A</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Severe hemophilia A Previously treat patient least 150 exposure day Factor VIII product Hypersensitivity recombinant Factor VIII product History current Factor VIII inhibitor Bleeding episode reason require Factor VIII treatment within 3 day study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Hemophilia A</keyword>
</DOC>